Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Yao ZhangXueyun ZhangJiajia HanYifei GuoJingjing HeFeifei YangRi-Cheng MaoYu-Xian HuangJi-Ming ZhangPublished in: Canadian journal of gastroenterology & hepatology (2023)
S100A8 and S100A9 are promising biomarkers for the analysis of risk stratification and prognosis in ACLF patients. In addition, combining them with the CLIF-C OFs may better predict the prognosis of ACLF.